The Evolution of an Ibogaine Treatment
Numerous pre-clinical and clinical studies have shown that Ibogaine reduces rates of self-administration of opiates, cocaine, amphetamines, alcohol and nicotine; signiﬁcantly attenuates opioid withdrawal symptoms; improves depression scores; and reduces cravings subsequent to detoxiﬁcation. With the rapidly increasing use of Ibogaine treatment for substance dependence, there is a pressing need to standardize screening processes and safety protocols that are evidence-based and shaped by ongoing clinical experience. This presentation follows the history of how Ibogaine has been administered to treat chemical dependence in clinical & underground settings, what providers have discovered so far, and the questions that still remain.
This video is from Psychedelic Science in the 21st Century, a conference taking in place in San Jose, California on April 15-18, 2010. The conference was organized by the Multidisciplinary Association for Psychedelic Studies (MAPS) in collaboration with the Heffter Research Institute, the Council on Spiritual Practices, and the Beckley Foundation.
This video was produced by Green Fuse Media, contact Nathan at email@example.com
To learn more about MAPS or to support our work, visit maps.org.